We have developed an intestine tissue chip using a novel microfluidic device that incorporates collagen membrane instead of the more typical Transwell membrane. The collagen allows establishment of a monolayer with tight junctions. We are using the device to study how the bacteria in the gut modulate activity of cytochrome P450 enzymes.
We have developed perfused microfluidic tissue-chips with (1) preadipocytes differentiated into adipocytes and (2) adipocytes with insulin resistance (IR). IR adipocytes displayed impaired fatty acid uptake which was rescued by treatment with rosiglitazone. These tissue-chips serve as a model for studying obesity and other metabolic disorders.
We have developed perfused microfluidic multi-cellular tissue constructs that exhibit long-term, stable function. We have established insulin resistance in the hepatocytes and have used this model to test strategies that can alleviate disrupted insulin response.
One of the challenges of small microfluidic volumes is in analysis of proteins and small molecules that are indicative of cellular function. We have developed a panel of biochemical assays that can measure in real-time the secretions from cells cultured in microfluidic devices.